Runs medical studies that test new drugs for drug companies.
No change
Giverny Capital owns 253,931 shares of Medpace, worth about $134 million. That’s $5 of every $100 they have in stocks. They didn’t really buy or sell any between April and June.
Mar 31
256,081
Jun 30
253,931
The numbers
Shares they own
253,931
Change since Mar 31
−2,150
tiny change (0.8%)
Shares on Mar 31
256,081
Value on Jun 30, 2026
$134,479,318
about $134 million
Share of their money
4.5%
$5 of every $100 · 7th of 49
Price per share on Jun 30
$529.59
Kind
Shares
More about Medpace ›
The value uses the price on Jun 30, 2026. The fund may have paid a different price.